Pathogenesis of cerebral malaria: Recent experimental data and possible applications for humans

Clinical Microbiology Reviews

Volumn 14, Issue 4, 2001, Pages 810-820

  Lou, J ^a   Lucas, R ^a   Grau, G E ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD VESSEL INJURY; BRAIN MALARIA; ENDOTHELIUM CELL; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; REVIEW; THROMBOCYTE;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; HUMANS; MALARIA, CEREBRAL; MICE; PLASMODIUM BERGHEI; RETINA; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MURINAE; PROTOZOA;

EID: 0034761722     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.14.4.810-820.2001     Document Type: Review

References (126)

1. Plasmodium-coatneyi-infected rhesus monkeys - A primate model for human cerebral malaria
2. A study on the pathogenesis of human cerebral malaria and cerebral babesiosis
3. Plasmodium falciparum varies in its ability to induce tumor necrosis factor
4. Immunization of rats against malaria: A new model
5. Monoclonal antibody OKM5 inhibits in vitro binding of Plasmodium falciparum infected erythrocytes to monocytes, endothelial, and C32 melanoma cells
6. Stimulators of tumour necrosis factor production released by damaged erythrocytes
7. Growth characteristics of cultured human macrovascular venous and arterial and microvascular endothelial cells
8. Organ-derived microvessel endothelial cells exhibit differential responsiveness to thrombin and other growth factors
9. Cerebral malaria: The sequestration hypothesis
10. Early microvascular changes in murine cerebral malaria detected in retinal wholemounts
11. Lymphocyte-T interferon-gamma production induced by Plasmodium falciparum antigen is high in recently infected non-immune and low in immune subjects
12. Roles of tumour necrosis factor in the illness and pathology of malaria
13. Malaria mimicry with tumor necrosis factor - Contrasts between species of murine malaria and Plasmodium falciparum
14. The cytokine theory of human cerebral malaria
15. Tumour necrosis factor-alpha and macrophages in Plasmodium-berghei-induced cerebral malaria
16. Profiles of cytokine production in relation with susceptibility to experimental cerebral malaria
17. Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria
18. Cerebral malaria in adult Zambian Africans
19. Plasmodium berghei: Premunition, sterile immunity, and loss of immunity in mice
20. Chronic, patent Plasmodium berghei malaria in splenectomized mice
21. Intra-erythrocytic Plasmodium falciparum induces up-regulation of inter-cellular adhesion molecule-1 on human endothelial cells in vitro
22. Late treatment with anti-LFA-1 (CD11a) antibody prevents cerebral malaria in a mouse model
23. Role of ICAM-1 (CD54) in the development of murine cerebral malaria
24. Multiple adhesive phenotypes linked to rosetting binding of erythrocytes in Plasmodium falciparum malaria
25. Virulent P. berghei malaria: Prolonged survival and decreased cerebral pathology in T-cell-deficient nude mice
26. Tumor necrosis factor-alpha is required in the protective immune response against mycobacterium tuberculosis in mice
27. A nonhuman primate model for human cerebral malaria: Rhesus monkeys experimentally infected with Plasmodium fragile
28. Transgenic mice expressing soluble TNF-R1-IgG3 molecules are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections
29. Isolation and characterization of brain microvascular endothelial cells from saimiri monkeys - An in vitro model for sequestration of Plasmodium falciparum-infected erythrocytes
30. Plasmodium-falciparum - Diversity of isolates from Malawi in their cytoadherence to melanoma cells and monocytes in vitro
31. Role of cytokines and adhesion molecules in malaria immunopathology
32. Cerebral malaria: Mediators, mechanical obstruction or more?
33. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria
34. Monoclonal antibody against interferon-gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor
35. TNF in vascular pathology: Importance of platelet-endothelium interactions
36. TNF-induced microvascular pathology in the Th1-mediated lesions of mouse cerebral malaria - Possible new mechanisms
37. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria
38. Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria
39. TNF-induced microvascular pathology: Active role for platelets and importance of the LFA-1/ICAM-1 interaction
40. Tumor necrosis factor and disease severity in children with falciparum malaria
41. An improved microassay for Plasmodium falciparum cytoadherence using stable transformants of chinese hamster ovary cells expressing CD36 or intercellular adhesion molecule-1
42. Immunopathology of cerebral malaria: Morphological evidence of parasite sequestration in murine brain microvasculature
43. Characterization of Plasmodium falciparum erythrocyte and P-selectin interaction under flow conditions
44. Molecular mechanisms of cytoadherence in malaria
45. T lymphocyte-dependent development of cerebral symptoms in Wm/MS rats infected with Plasmodium berghei
46. Cytokine profile suggesting that murine cerebral malaria is an encephalitis
47. Cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelium is regulated by cytokines and phorbol ester
48. Cerebral malaria in mice: Demonstration of cytoadherence of infected red blood cells and microrheologic correlates
49. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
50. Ishemia/reperfusion injury in human kidney transplantation: An immunohistochemical analysis of changes after reperfusion
51. TNF-inducing malaria toxin - A sheep in wolf's clothing
52. Malarial toxins and the regulation of parasite density
53. Response to monoclonal anti-TNF antibody in children with cerebral malaria
54. Differential adhesion of granulocytes to five distinct phenotypes of cultured microvascular endothelial cells
55. Differential reactivity of brain microvascular endothelial cells to TNF reflects the genetic susceptibility to cerebral malaria
56. Platelets play an important role in TNF-induced microvascular endothelial cell pathology
57. Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells
58. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria
59. Respective role of TNF receptors in the development of experimental cerebral malaria
60. Immunopathological aspects of Plasmodium berghei infection in five strains of mice II. Immunopathology of cerebral and other tissue lesions during the infection
61. Role of platelet adhesion in homeostasis and immunopathology
62. Fibrinogen deposition at the post-ischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo
63. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria
64. Redistribution and degeneration of retinal astrocytes in experimental murine cerebral malaria: Relationship to disruption of the blood-retinal barrier
65. Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: Evidence for production by microglia and astrocytes
66. Expression of major histocompatibility complex antigens on mouse brain microvascular endothelial cells in relation to susceptibility to cerebral malaria
67. Platelet thrombi in rejection episodes
68. Primary culture of human lung microvessel endothelial cells: An useful in vitro model for studying Plasmodium falciparum-infected erythrocyte cytoadherence
69. Comparisons between microvascular changes in cerebral and non-cerebral malaria in mice, using the retinal whole-mount technique
70. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice
71. Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor
72. Human cerebral malaria: A pathological study
73. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes
74. Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria
75. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture
76. Mice deficient for the 55-kDa tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to Listeria monocytogenes infection
77. Signal transduction pathways involved in tumour necrosis factor secretion by Plasmodium falciparum-stimulated human monocytes
78. Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD11 antibodies
79. Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice
80. Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor, and immune interferon
81. Platelet receptors involved in Plasmodium falciparum growth inhibition
82. Immunopathological changes in human cerebral malaria
83. Cytoadhesin of Plasmodium falciparum ring-stage-infected erythrocytes
84. Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells
85. Pathogenesis of cerebral malaria in golden hamsters and inbred mice
86. Cytoadherence characteristics of Plasmodium falciparum-infected erythrocytes from Malawian children with severe and uncomplicated malaria
87. Mice lacking the tumour necrosis factor receptor-1 are resistant to TNF-Mediated toxicity but highly susceptible to infection by Listeria monocytogenes
88. Cytoadherence of knobby and knobless Plasmodium-falciparum-infected erythrocytes
89. Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response
90. Malaria toxins revisited
91. Signal transduction in host cells by a glycosyl phosphatidyl inositol toxin of malaria parasites
92. The isolation and culture of microvascular endothelium
93. Differential sequestration of parasitized erythrocytes in the cerebrum and cerebellum in human cerebral malaria
94. Mortality and platelet depletion occur independently of fibrinogen consumption in murine models of tumor necrosis factor-mediated systemic inflammatory responses
95. Tumor necrosis factor and severe malaria
96. Knob proteins in falciparum malaria
97. Membrane proteins involved in the adherence of Plasmodium falciparum-infected erythrocytes to the endothelium
98. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain
99. Multi-organ erythrocyte sequestration and ligand expression in rhesus monkeys infected with Plasmodium coatneyi malaria
100. Plasmodium falciparum: Cytoadherence of malaria-infected erythrocytes to human brain capillary and umbilical vein endothelial cells - A comparative study of adhesive ligands
101. TNF receptors in murine Candida albicans infection-evidence for an important role of TNF receptor p55 in anti-fungal defense
102. Detection of an LFA-1 epitope on the surface of erythrocytes infected with a strain of P. falciparum
103. Brain histomorphology in protein deprived rhesus monkeys with fatal malarial infection
104. The squirrel monkey as an experimental model for Plasmodium falciparum erythrocyte rosette formation
105. PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes
106. Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor
107. Cerebral malaria
108. An immunohistochemical study of the pathology of fatal malaria - Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration
109. In vitro and ex vivo models of sequestration in Plasmodium-Falciparum infection
110. Falciparum malaria-infected erythrocytes specifically bind to cultured endothelial cells
111. Cytoadherence of knobless Plasmodium falciparum-infected erythrocytes and its inhibition by a human monoclonal antibody
112. Promiscuity of clinical Plasmodium falciparum isolates for multiple adhesion molecules under flow conditions
113. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria
114. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication
115. The role of T-cells in pathogenesis and protective immunity to murine malaria
116. Severe and complicated malaria
117. Cytoadherence of Plasmodium-falciparum-infected erythrocytes to human umbilical vein and human dermal microvascular endothelial cells under shear conditions
118. In vivo sequestration of Plasmodium falciparum-infected human erythrocytes: A severe combined immunodeficiency mouse model for cerebral malaria
119. Plasmodium falciparum: Involvement of additional receptors in the cytoadherence of infected erythrocytes to microvascular endothelial cells
120. Sulfated polyanions inhibit invasion of erythrocytes by plasmodial merozoites and cytoadherence of endothelial cells to parasitized erythrocytes
121. Cerebral malaria in a virulent rodent plasmodial infection